“…Accumulated evidence on the nutraceutical effects of NRCs and NRC-derived natural products on menopausal osteoporosis and obesity has been gathered by numerous studies. Gallotannin derivatives (e.g., galloyl glucosides, methyl gallate, ellagic acid, and epicatechin gallate) and flavonoids (e.g., catechin, kaempferol, quercetin, isoquercetin, and luteolin) have been shown to negatively regulate osteoclast differentiation and positively affect osteoblast differentiation in vitro, exerting protective effects on bone loss induced by estrogen deficiency or lipopolysaccharides in vivo [29][30][31][32][33]. Besides anti-osteoporotic activities, the phenolic fractions and gallotannins, including penta-O-galloyl-β-D-glucose from NRCs, have been shown to inhibit pancreatic lipase activity involved in fat absorption [11,34].…”